While a clear view on the relevance of all the ACSL isoforms in RCC is not yet available, it seems that at least ACSL3 could serve as a potential prognostic biomarker for immune infiltration in ccRCC [118]. Here, ACSL3 is linked to nonpapillary renal cell carcinoma.